Biopolymer-protected graphene-Fe3O4 nanocomposite based wearable microneedle sensor: toward real-time continuous monitoring of dopamine

Keerthanaa M R,Lakshmi R Panicker,Roger Narayan,Yugender Goud Kotagiri,Keerthanaa M. R.,Lakshmi R. Panicker

DOI: https://doi.org/10.1039/d4ra00110a

IF: 4.036

2024-02-28

RSC Advances

Abstract:Neurological disorders can occur in the human body as a result of nano-level variations in the neurotransmitter levels. Patients affected by neuropsychiatric disorders, that are chronic require continuous monitoring of these neurotransmitter levels for effective disease management. The current work focus on developing a highly sensitive and personalized sensor for continuous monitoring of dopamine. Here we propose a wearable microneedle-based electrochemical sensor, to continuously monitor dopamine in interstitial fluid (ISF). A chitosan-protected hybrid nanomaterial Fe 3 O 4 –GO composite has been used as a chemical recognition element protected by Nafion antifouling coating layer. The morphological and physiochemical characterizations of the nanocomposite were carried out with XRD, XPS, FESEM, EDAX and FT-IR. The principle of the developed sensor relies on orthogonal detection of dopamine with square wave voltammetry and chronoamperometric techniques. The microneedle sensor array exhibited an attractive analytical performance toward detecting dopamine in phosphate buffer and artificial ISF. The limit of detection (LOD) of the developed sensor was observed to be low, 90 nM in square wave voltammetry and 0.6 μM in chronoamperometric analysis. The practical applicability of the microneedle sensor array has been demonstrated on a skin-mimicking phantom gel model. The microneedle sensor also exhibited good long-term storage stability, reproducibility, and sensitivity. All of these promising results suggest that the proposed microneedle sensor array could be reliable for the continuous monitoring of dopamine.

chemistry, multidisciplinary

What problem does this paper attempt to address?

The problem this paper attempts to address is the development of a highly sensitive and personalized sensor for continuous monitoring of dopamine levels. Specifically, the research focuses on designing a wearable microneedle sensor capable of continuously detecting dopamine through interstitial fluid (ISF). This sensor is particularly important for patients with neuropsychiatric disorders (such as Parkinson's disease, Alzheimer's disease, etc.), as the management of these diseases requires continuous monitoring of neurotransmitter levels.

### Main Contributions of the Paper
1. **Development of a New Sensor**: A wearable microneedle sensor based on graphene-Fe₃O₄ nanocomposite material is proposed for real-time continuous monitoring of dopamine.
2. **Improving Detection Sensitivity**: By using chitosan-protected Fe₃O₄-graphene oxide (GO) composite material as the chemical recognition element and combining it with a Nafion anti-fouling coating layer, the detection sensitivity of the sensor is improved.
3. **Validation of Sensor Performance**: The sensor's detection performance in phosphate buffer solution and artificial ISF was validated using various electrochemical techniques (such as square wave voltammetry and constant current method).
4. **Practical Application Testing**: The practical application capability of the sensor was demonstrated on a skin-simulating gel model, proving its superior performance in long-term storage stability, reproducibility, and sensitivity.

### Problems Addressed
- **Continuous Monitoring of Neurotransmitter Levels**: Current medical technology usually requires patients to visit hospitals for long-term diagnosis and treatment, whereas this wearable microneedle sensor can achieve continuous monitoring of neurotransmitter levels in patients' daily lives.
- **Improving Detection Accuracy**: By optimizing the design and material selection of the sensor, the sensitivity and selectivity for detecting dopamine are improved, making it more reliable in practical applications.
- **Reducing Invasiveness**: Traditional blood testing methods are highly invasive, while this microneedle sensor detects through interstitial fluid, reducing patient discomfort and potential risks.

In summary, this paper addresses the challenge of continuous monitoring of neurotransmitter levels by developing a high-performance wearable microneedle sensor, providing a new tool for the management and treatment of neuropsychiatric disorders.